TAM
CRL icon

Tiverton Asset Management’s Charles River Laboratories CRL Stock Holding History

Tiverton Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$314K Hold
2,369
– – 0.01% 489
2019
Q2 		$336K Sell
2,369
-1,872
-44% -$254K 0.01% 481
2019
Q1 		$616K Buy
+4,241
New +$557K 0.03% 304

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tiverton Asset Management's CRL Position: Q3 2019 in Review

Tiverton Asset Management held its Charles River Laboratories (CRL) position steady in Q3 2019 at 2,369 shares worth $314K. The position accounts for 0.01% of the portfolio, ranked #489.

Tiverton Asset Management first reported a position in CRL in Q1 2019 and has held it in 3 quarters since. The position peaked at $616K in Q1 2019. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

  • Tiverton Asset Management held 2,369 shares of Charles River Laboratories worth $314K as of Q3 2019.
  • Tiverton Asset Management left its Charles River Laboratories share count unchanged in Q3 2019.
  • Charles River Laboratories made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #489 holding.
  • Tiverton Asset Management first reported a position in Charles River Laboratories in Q1 2019 and has held it in 3 quarters since.
  • Tiverton Asset Management's Charles River Laboratories position peaked at $616K in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.